marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Avadel Pharmaceuticals plc Financial Ratios 2011-2024 | AVDL
Annual Financial Ratios Avadel Pharmaceuticals plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-6.4 | -4.1 | -6.1 | 55.0 | -8.2 | -1.1 | 6.5 | -9.1 | 10.1 | -6.1 | -6.4 | -32.0 | -17.6 |
P/S |
36.7 | - | - | 17.3 | 4.6 | 1.0 | 2.6 | 2.5 | 2.4 | 35.3 | 12.3 | 4.0 | 4.7 |
EPS |
-2 | -2.3 | -1.3 | 0.1 | -0.9 | -2.5 | 1.7 | -1 | 1.0 | -2.4 | -1.7 | -0.1 | -0.4 |
EV (Enterprise Value) |
1.07 B | 641 M | 590 M | 465 M | 444 M | 281 M | 596 M | 542 M | 494 M | 631 M | 395 M | 187 M | 190 M |
EBITDA per Share |
-1.7 | -1.62 | -1.45 | -0.684 | -0.428 | -1.45 | 1.6 | 1.41 | 2.83 | -0.597 | -0.74 | -0.671 | -0.253 |
EV/EBITDA |
-6.9 | -12.2 | -24.0 | -3.9 | 6.6 | 5.8 | 3.0 | -27.8 | -18.8 | -8.1 | -24.8 | ||
PEG |
-0.27 | 0.26 | 0.4 | 0.48 | -0.13 | 0.0 | 0.02 | 0.05 | 0.07 | 0.16 | 0.01 | -0.5 | -6.5 |
P/B |
11.7 | -26.5 | 6.0 | 2.4 | -9.3 | 37.1 | 5.2 | 9.0 | 6.1 | 20.9 | -29.0 | 3.4 | 5.2 |
P/CF |
-8.0 | -8.0 | -6.1 | -7.9 | -7.1 | -1.0 | -12.0 | 21.3 | 5.0 | -42.2 | -12.7 | -4.3 | -12.6 |
ROE % |
-182.67 | 650.10 | -98.83 | 4.33 | 113.79 | -3428.20 | 79.77 | -98.12 | 59.91 | -341.06 | 451.27 | -10.58 | -29.45 |
ROA % |
-97.32 | -103.52 | -31.27 | 2.26 | -21.94 | -50.08 | 26.96 | -16.81 | 18.91 | -48.74 | -36.92 | -2.75 | -12.64 |
ROCE % |
-157.11 | 466.12 | -109.33 | -12.36 | -14.57 | -39.86 | 36.59 | 24.21 | 61.62 | -32.27 | -28.95 | -19.45 | -18.76 |
Current Ratio |
2.1 | 0.9 | 1.5 | 17.4 | 2.3 | 3.3 | 1.4 | 2.9 | 3.4 | 1.6 | 0.8 | 1.7 | 2.0 |
DSO |
79.0 | - | - | 633.8 | 73.8 | 49.2 | 34.8 | 46.2 | 29.5 | 214.6 | 342.1 | 183.3 | 87.8 |
DIO |
2239.2 | - | - | - | 107.5 | 99.4 | 137.9 | 89.8 | 138.9 | 726.0 | 315.7 | 94.7 | 97.3 |
DPO |
4168.4 | - | - | 186.5 | 183.6 | 73.0 | 167.4 | 195.8 | 353.1 | 865.7 | 427.9 | 224.0 | 227.7 |
Operating Cycle |
2318.2 | - | - | 633.8 | 181.3 | 148.6 | 172.6 | 136.0 | 168.3 | 940.6 | 657.8 | 278.0 | 185.1 |
Cash Conversion Cycle |
-1850.2 | - | - | 447.3 | -2.3 | 75.6 | 5.2 | -59.8 | -184.8 | 74.9 | 229.8 | 54.0 | -42.6 |
All numbers in USD currency
Quarterly Financial Ratios Avadel Pharmaceuticals plc
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.03 | -0.14 | -0.3 | - | -0.41 | -0.83 | -0.48 | - | -0.33 | -1.07 | -0.45 | - | -0.38 | -0.33 | -0.23 | - | -0.2 | 0.57 | -0.02 | - | -0.24 | -0.23 | -0.35 | - | -0.43 | -0.09 | -0.32 | - | 0.54 | 0.7 | 0.63 | - | -0.48 | -0.48 | -0.15 | - | -0.69 | -0.42 | 0.29 | - | -0.26 | -0.55 | -0.94 | - | -0.25 | -1.29 | -0.35 | - | -0.26 | -0.24 | - | - | - | -0.14 | -0.2 |
EBITDA per Share |
- | - | -0.28 | - | - | - | -0.43 | - | -0.27 | -0.5 | -0.48 | - | -0.43 | -0.37 | -0.25 | - | -0.21 | 0.76 | -0.15 | - | -0.07 | -0.09 | -0.21 | - | -0.23 | 0.03 | -0.28 | - | 0.72 | 0.87 | 0.83 | - | -0.11 | -0.09 | 0.23 | - | -0.12 | 0.1 | 0.34 | - | -0.36 | -0.43 | -0.73 | - | -0.27 | -1.35 K | -0.36 | - | -0.26 | -0.25 | 0.03 | - | - | -148 | -0.16 |
ROE % |
-90.99 | -120.41 | -145.74 | 2.73 | 164.67 | 359.55 | 2308.63 | 2018.19 | 1995.95 | 1811.77 | -108.78 | -48.55 | -55.77 | -40.75 | -5.25 | 11.28 | 41.64 | 79.21 | 89.65 | 104.41 | -462.89 | -1060.55 | -1213.69 | -1131.12 | -1105.78 | -513.15 | -355.68 | 89.41 | 41.88 | -30.98 | -112.22 | -109.37 | -149.98 | -143.06 | -120.00 | -47.83 | -72.92 | -57.39 | -69.43 | -95.60 | -54.25 | 12.17 | 375.04 | 367.79 | 367.79 | 303.12 | -46.66 | -46.62 | -23.29 | -23.29 | 0.04 | - | - | - | - |
ROA % |
-44.58 | -60.78 | -84.06 | -71.79 | -85.61 | -81.58 | -89.69 | -65.94 | -74.27 | -68.78 | -35.54 | -19.85 | -23.61 | -19.03 | -2.19 | 5.87 | 0.02 | -2.08 | -17.67 | -20.13 | -28.42 | -30.85 | -26.98 | -16.52 | -7.96 | 8.88 | 22.11 | 30.21 | 22.07 | 5.36 | -14.19 | -18.74 | -31.80 | -36.70 | -36.41 | -15.47 | -21.58 | -14.64 | -18.87 | -32.84 | -38.30 | -37.66 | -53.34 | -33.21 | -33.21 | -32.17 | -8.85 | -8.84 | -4.42 | -4.42 | 0.01 | - | - | - | - |
ROCE % |
- | - | - | - | 136.33 | 272.67 | 1171.14 | 982.98 | 957.04 | 794.77 | -122.15 | -55.24 | -63.68 | -46.18 | -2.92 | 12.37 | 26.57 | 49.22 | 39.64 | 57.42 | -449.60 | -970.81 | -1086.24 | -1061.33 | -1030.81 | -493.28 | -353.22 | 109.35 | 70.87 | 1.87 | -65.45 | -52.36 | -73.32 | -55.79 | -29.60 | -15.59 | -30.01 | -23.47 | -36.40 | -45.37 | -53.58 | -47.36 | -67.11 | -42.13 | -42.13 | -39.32 | -10.78 | -10.82 | -5.43 | -5.43 | -0.04 | - | - | - | - |
Current Ratio |
1.9 | 1.8 | 1.9 | 2.1 | 2.2 | 3.5 | 0.8 | 0.9 | 0.9 | 1.0 | 1.3 | 1.5 | 1.6 | 1.7 | 1.9 | 2.1 | 2.1 | 2.1 | 2.1 | 0.8 | 0.8 | 0.8 | 0.8 | 1.0 | 1.0 | 1.0 | 1.0 | 1.5 | 1.5 | 1.5 | 1.5 | 1.2 | 1.2 | 1.2 | 1.2 | 1.5 | 1.5 | 1.5 | 1.5 | 1.2 | - | - | - | 166.6 | - | - | - | - | - | - | - | - | - | - | - |
DSO |
64.3 | 61.6 | 58.4 | - | 52.1 | - | - | - | - | - | - | - | - | - | - | - | - | 65.5 | 63.6 | - | 53.1 | 43.0 | 54.4 | - | 52.1 | 35.4 | 35.8 | - | 34.0 | 29.1 | 28.4 | - | 50.7 | 41.9 | 31.9 | - | 14.4 | 13.6 | 12.1 | - | 43.0 | 81.1 | 102.1 | - | 92.9 | 41.5 | - | - | 47.1 | 84.3 | 34.6 | - | - | - | - |
DIO |
218.0 | 413.1 | 668.7 | - | 2622.5 | - | - | - | - | - | - | - | - | - | - | - | - | 48.9 | 131.7 | - | 115.4 | 89.9 | 116.5 | - | 139.5 | 123.9 | 75.6 | - | 148.2 | 123.2 | 110.1 | - | 104.5 | 76.1 | 80.9 | - | 160.3 | 129.5 | 136.8 | - | 287.1 | 962.5 | 445.1 | - | 124.7 | 65.9 | 69.7 | - | 48.6 | 103.3 | 123.9 | - | - | - | - |
DPO |
131.3 | 470.6 | 911.1 | - | 9768.0 | 27639.9 | - | - | - | - | - | - | - | - | - | - | - | 81.5 | 167.8 | - | 197.2 | 153.7 | 134.2 | - | 102.5 | 91.0 | 76.0 | - | 180.0 | 149.6 | 170.5 | - | 228.0 | 165.9 | 142.0 | - | 220.7 | 258.5 | 233.6 | - | 314.2 | 1127.1 | 676.2 | - | 194.0 | 116.2 | 164.9 | - | 144.7 | 278.2 | 297.5 | - | - | - | - |
Operating Cycle |
282.3 | 474.7 | 727.1 | - | 2674.6 | - | - | - | - | - | - | - | - | - | - | - | - | 114.4 | 195.3 | - | 168.5 | 133.0 | 170.9 | - | 191.7 | 159.3 | 111.4 | - | 182.2 | 152.3 | 138.4 | - | 155.3 | 118.0 | 112.8 | - | 174.7 | 143.1 | 148.9 | - | 330.1 | 1043.7 | 547.2 | - | 217.6 | 107.4 | 69.7 | - | 95.7 | 187.6 | 158.4 | - | - | - | - |
Cash Conversion Cycle |
151.0 | 4.1 | -184.0 | - | -7093.4 | -27639.9 | - | - | - | - | - | - | - | - | - | - | - | 32.9 | 27.6 | - | -28.7 | -20.7 | 36.8 | - | 89.2 | 68.3 | 35.4 | - | 2.2 | 2.7 | -32.1 | - | -72.7 | -48.0 | -29.2 | - | -46.0 | -115.4 | -84.8 | - | 15.9 | -83.5 | -129.0 | - | 23.6 | -8.8 | -95.2 | - | -49.0 | -90.6 | -139.1 | - | - | - | - |
All numbers in USD currency